Skip to Content

MBI-226 Approval Status

FDA Approved: No
Brand name: MBI-226
Generic name: omiganan pentahydrochloride
Company: Micrologix Biotech Inc
Treatment for: Infection Prophylaxis

Development Status and FDA Approval Process for MBI-226

DateArticle
Jan 21, 2004Micrologix Meets with FDA on MBI-226

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide